INVESTIGACIÓN BÁSICA

1. Microbial Signature in Adipose Tissue of Crohn’s Disease Patients.
Serena C., Queipo-Ortuño M., Millan M., et al. J Clin Med. 2020;9(8):E2448. Published 2020 Jul 31. doi:10.3390/jcm9082448

2. Evaluation of Changes in Gut Microbiota in Patients with Crohn’s Disease after Anti-Tnfα Treatment: Prospective Multicenter Observational Study.
Sanchis-Artero L., Martínez-Blanch J.F., Manresa-Vera S., Cortés-Castell E., Rodriguez-Morales J., Cortés-Rizo X. Int J Environ Res Public Health. 2020;17(14):5120. Published 2020 Jul 15. doi:10.3390/ijerph17145120

3. Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn’s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways.
Ortiz T., Argüelles-Arias F., Illanes M., et al. Nutrients. 2020;12(6):1752. Published 2020 Jun 11. doi:10.3390/nu12061752

4. Transcriptomic identification of TMIGD1 and its relationship with the ileal epithelial cell differentiation in Crohn’s disease.
Zabana Y., Lorén V., Domènech E., et al. Am J Physiol Gastrointest Liver Physiol. 2020;319(2):G109-G120. doi:10.1152/ajpgi.00027.2020

5. Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development.
Ortiz-Masiá D., Gisbert-Ferrándiz L., Bauset C., et al. Cells. 2020;9(5):1104. Published 2020 Apr 29. doi:10.3390/cells9051104

6. Adipose stem cells from patients with Crohn’s disease show a distinctive DNA methylation pattern.
Serena C., Millan M., Ejarque M., et al. Clin Epigenetics. 2020;12(1):53. Published 2020 Apr 6. doi:10.1186/s13148-020-00843-3

7. Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D.
Gisbert-Ferrándiz L., Cosín-Roger J., Hernández C., et al. Nutrients. 2020;12(4):973. Published 2020 Apr 1. doi:10.3390/nu12040973

8. Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease.
Abarca-Zabalía J., García M.I., Lozano Ros A., et al. Int J Mol Sci. 2020;21(2):676. Published 2020 Jan 20. doi:10.3390/ijms21020676

9. Mucosal microbial load in Crohn’s disease: A potential predictor of response to faecal microbiota transplantation.
Sarrabayrouse G., Landolfi S., Pozuelo M., et al. EBioMedicine. 2020;51:102611. doi:10.1016/j.ebiom.2019.102611

10. Different Intraepithelial CD3+ Cell Numbers in Crohn’s Disease and Ulcerative Colitis.
Escudero-Hernández C., Montalvillo E., Antolín B., et al. Inflamm Bowel Dis. 2020;26(3):e14-e15. doi:10.1093/ibd/izz309

11. Gammadelta T cells as a predictor of surgical relapse of Crohn’s disease.
Andreu-Ballester J.C., Catalán-Serra I., Gil-Borrás R., et al. [published online ahead of print, 2019 Dec 18]. Clin Res Hepatol Gastroenterol. 2019;S2210-7401(19)30254-2. doi:10.1016/j.clinre.2019.11.003

12. Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn’s Disease.
Moret-Tatay I., Cerrillo E., Sáez-González E., et al. Clin Transl Gastroenterol. 2019;10(10):e00083. doi:10.14309/ctg.0000000000000083

13. Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease.
Salvador-Martín S., López-Cauce B., Nuñez O., et al. Pharmacol Res. 2019;149:104478. doi:10.1016/j.phrs.2019.104478

14. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease.
Chaparro M., Aterido A., Guerra I., et al. Therap Adv Gastroenterol. 2019;12:1756284819867848. Published 2019 Sep 25. doi:10.1177/1756284819867848

15. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
Ortega Moreno L., Fernández-Tomé S., Chaparro M., et al. [published online ahead of print, 2020 Jun 17]. Inflamm Bowel Dis. 2020;izaa151. doi:10.1093/ibd/izaa151

16. Microbiota Insights in Clostridium Difficile Infection and Inflammatory Bowel Disease.
Rodríguez C., Romero E., Garrido-Sanchez L., et al. Gut Microbes. 2020;12(1):1725220. doi:10.1080/19490976.2020.1725220

17. The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis.
Pascual-Itoiz M.A., Peña-Cearra A., Martín-Ruiz I., et al. Sci Rep. 2020;10(1):572. Published 2020 Jan 17. doi:10.1038/s41598-019-57348-0